J K Luce, E Frei, E A Gehan, C A Coltman, R Talley, R W Monto. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAge FactorsAntineoplastic Agents/therapeutic useBenzoates/therapeutic useBlood Cell CountBone MarrowEvaluation Studies as TopicHodgkin Disease/drug therapyHodgkin Disease/radiotherapyHumansMechlorethamine/administration & dosageMechlorethamine/adverse effectsMechlorethamine/therapeutic useMiddle AgedPrednisone/administration & dosagePrednisone/adverse effectsPrednisone/therapeutic useProcarbazine/administration & dosageProcarbazine/adverse effectsProcarbazine/therapeutic useRemission, SpontaneousSex FactorsVincristine/administration & dosageVincristine/adverse effectsVincristine/therapeutic use
Substances： See more » Antineoplastic AgentsBenzoatesProcarbazineMechlorethamineVincristinePrednisone
Year: 1973 PMID： 4688037 DOI： 10.1001/archinte.131.3.391
Source DB: PubMed Journal: Arch Intern Med ISSN： 0003-9926